2910 related articles for article (PubMed ID: 7679614)
1. Interferons. New additions and indications for use.
Stadler R; Ruszczak Z
Dermatol Clin; 1993 Jan; 11(1):187-99. PubMed ID: 7679614
[TBL] [Abstract][Full Text] [Related]
2. Interferons in dermatology: biology, pharmacology, and clinical applications.
Ruszczak Z; Schwartz RA
Adv Dermatol; 1997; 13():235-88. PubMed ID: 9551146
[No Abstract] [Full Text] [Related]
3. The clinical application of the interferons: a review. NSW Therapeutic Assessment Group.
Stuart-Harris RC; Lauchlan R; Day R
Med J Aust; 1992 Jun; 156(12):869-72. PubMed ID: 1376397
[TBL] [Abstract][Full Text] [Related]
4. Interferon in the treatment of cutaneous T-cell lymphoma.
Olsen EA; Bunn PA
Hematol Oncol Clin North Am; 1995 Oct; 9(5):1089-107. PubMed ID: 8522486
[TBL] [Abstract][Full Text] [Related]
5. Interferons in dermatology. Present-day standard.
Stadler R
Dermatol Clin; 1998 Apr; 16(2):377-98. PubMed ID: 9589211
[TBL] [Abstract][Full Text] [Related]
6. [Current status of interferon therapy].
Dittrich C
Wien Med Wochenschr; 1986 Apr; 136(7-8):163-72. PubMed ID: 2425497
[TBL] [Abstract][Full Text] [Related]
7. [Therapeutic use of interferon: current trends and prospects].
Laghi V; Toccaceli F
Medicina (Firenze); 1990; 10(2):201-11. PubMed ID: 1703261
[No Abstract] [Full Text] [Related]
8. [Therapeutic use of alpha interferon in metastasizing malignant melanoma, disseminated Kaposi sarcoma and severe Behçet disease].
Stadler R; Bratzke B; Orfanos CE
Hautarzt; 1987 Aug; 38(8):453-60. PubMed ID: 3654216
[TBL] [Abstract][Full Text] [Related]
9. HIV-associated Kaposi sarcoma: pathogenesis and therapy.
Potthoff A; Brockmeyer NH
J Dtsch Dermatol Ges; 2007 Dec; 5(12):1091-4. PubMed ID: 17944950
[TBL] [Abstract][Full Text] [Related]
10. Perspectives of cytokine treatment in malignant skin tumors.
Garbe C
Recent Results Cancer Res; 1995; 139():349-69. PubMed ID: 7597303
[TBL] [Abstract][Full Text] [Related]
11. Interferons in the treatment of skin disease.
Ringenberg QS; Anderson PC
Int J Dermatol; 1986 Jun; 25(5):273-9. PubMed ID: 2424849
[No Abstract] [Full Text] [Related]
12. The Use of Interferons in the Treatment of Cutaneous T-Cell Lymphoma.
Spaccarelli N; Rook AH
Dermatol Clin; 2015 Oct; 33(4):731-45. PubMed ID: 26433845
[TBL] [Abstract][Full Text] [Related]
13. [Interferons in the therapy of solid tumors].
Tomao S; Mozzicafreddo A; Raffaele M; Romiti A; Papò MA; Campisi C
Clin Ter; 1995; 146(8-9):491-502. PubMed ID: 8536432
[TBL] [Abstract][Full Text] [Related]
14. Interferon in AIDS.
Krown SE; Real FX; Vadhan-Raj S; Oettgen HF
J Exp Pathol; 1987; 3(4):681-91. PubMed ID: 2457669
[TBL] [Abstract][Full Text] [Related]
15. [Aseptic skin necrosis after subcutaneous injection of alpha interferon].
Rasokat H; Bendick C; Wemmer U; Steigleder GK
Dtsch Med Wochenschr; 1989 Mar; 114(12):458-60. PubMed ID: 2924699
[TBL] [Abstract][Full Text] [Related]
16. [Alpha interferons--new therapeutic modalities].
Bajcetić M; Zigon N; Samardzić R; Beleslin DB
Med Pregl; 1998; 51(3-4):135-9. PubMed ID: 9611956
[TBL] [Abstract][Full Text] [Related]
17. AIDS-related Kaposi's sarcoma in a heterosexual female.
Ko CB; Walton S; Keczkes K; Greenstone M; Bury HP
Br J Dermatol; 1992 Jan; 126(1):74-6. PubMed ID: 1536765
[No Abstract] [Full Text] [Related]
18. New treatment helpful in Kaposi's sarcoma.
Nurs Stand; 1993 May 19-25; 7(35):17. PubMed ID: 8499297
[No Abstract] [Full Text] [Related]
19. [Therapeutic possibilities in HIV infection and AIDS].
Rasokat H
Z Hautkr; 1989 May; 64(5):374, 379-82, 387. PubMed ID: 2662667
[TBL] [Abstract][Full Text] [Related]
20. [Therapy of AIDS-induced Kaposi sarcoma and malignant melanoma with interferons].
Stadler R; Bratzke B; Mayer da Silva A; Orfanos CE
Onkologie; 1988 Aug; 11(4):166-76. PubMed ID: 3054668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
